Romero-Vélez G, Gómez-Pérez FJ, Aguayo A, Martínez-Benítez B, Pantoja JP, Sierra M, Velázquez-Fernández D, Herrera MF

Language: Spanish
References: 20
Page: 234-239
PDF size: 155.5 Kb.

ABSTRACT

Background. Primary adrenal malignancies are rare and have a dismal prognosis. We report our experience in both adrenocortical carcinomas and malignant pheochromocytomas who received medical care at our Institution between 1994 and 2009. Material and methods. The data bases of hospital discharges, surgery and pathology were reviewed looking for patients with diagnosis of primary adrenal malignant tumors. Clinical presentation, laboratory and image characteristics, surgical details, histopathology findings and outcome were analyzed. Results. A total of eight patients were identified, two men and six women with a mean age of 48.1 ± 15.7 years (31–80). Six patients presented with adrenocortical carcinomas and two had malignant pheochromocytomas. Of the six cortical tumors four were functioning. Five were stage II, two were stage III and one was stage IV. All patients underwent surgery as initial treatment. Six patients underwent open and two, laparoscopic adrenalectomy. Three patients received adjuvant chemotherapy. In a mean follow up of 32 ± 27 months, only three patients with stage II were alive and free of the disease. Conclusions. As in other series, primary adrenal carcinoma in our population proved to be a rare endocrine neoplasm with poor prognosis despite complete surgical resection. Treatment at initial stages provides better outcome.

REFERENCES

1. Venkatesh S, Hickey RC, Sellin RV, Fernandez JF, Samaan NA. Adrenal cortical carcinoma. Cancer 1989; 64: 765-9.

2. Proye CAG, Pattou FN, Armstrong J. Primary Adrenocortical Carcinoma. En: Linos D, van Heerden JA. Adrenal Glands. Springer. Germany; 2005, p. 131-42.

3. Wajchenberg B, Albergaria PM, Medonca B, et al. Adrenocortical carcinoma: clinical and laboratory observations. Cancer 2000; 88: 711-36.

4. Allolio B, Fassnacht M. Clinical review: Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 2006; 91: 2027-37.

5. Latronico AC, Chrousos GP. Extensive personal experience: adrenocortical tumors. J Clin Endocrinol Metab 1997; 82: 1317-24.

6. Sutton MG, Sheps SG, Lie JT. Prevalence of Clinically Unsuspected Pheochromocytoma. Review of a 50-Year Autopsy Series. Mayo Clin Proc 1981; 56: 354-60.

7. Nguyen-Martin MA, Hammer GD. Pheochromocytoma: An update on risk groups, diagnosis, and management. Hosp Physician 2006; 17-24.

8. Eisenhofer G, Bornstein SR, Brouwers FM, et al. Malignant Pheocromocytoma: current status and initiatives for future progress. Endocr Relat Cancer 2004; 11: 423-36.

9. Van Slooten H, Schaberg A, Smeenk D, Moolenaar AJ. Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer 1985; 55: 766-73.

10. Hough AJ, Hollifield JW, Page DL, Hartmann WH. Prognostic factors in adrenal cortical tumours. Am J Clin Pathol 1979; 72: 390-9.

11. Thompson LDR, et al. Malignant adrenal phaeochromocytoma. In: De Lellis RA, Lloyd RV, Philipp UH. WHO Classification of Tumors: Pathology and genetics of tumours of endocrine organs. Francia: IARC Press; 2004, p. 147-50.

12. Bovio S, Cataldi A, Reimondo G, et al. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 2006; 29: 298-302.

13. Abecassis M, Mcloughlin MJ, Langer B, Kudlow JE. Serendipitous adrenal masses: prevalence, significance, and management. Am J Surg 1985; 149: 783-8.

14. Dackiw AP, Lee JE, Gagel RF, Evans DB. Adrenal cortical carcinoma. World J Surg 2001; 25: 914-26.

15. Libe R, Fratticci A, Bertherat J. Adrenocortical cancer: pathophysiology and clinical management. Endocr Relat Cancer 2007; 14: 13-28.

16. De Fraipont F, El Atifi M, Cherradi N, et al. Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy. J Clin Endocrinol Metab 2005; 90: 1819-29.

17. Bilimoria KY, Shen WT, Elaraj D, et al. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer 2008; 113: 3130-6.

18. McCauley LR, Nguyen MM. Laparoscopic radical adrenalectomy for cancer: long term outcomes. Curr Opin Urol 2008; 18: 134-8.

19. Mezzadri NA, Mandry AC, Sinagra DL, Falco JE, Férnandez- Vila JM. Abordaje laparoscópico en el tratamiento de las tumoraciones adrenales malignas. Cir Esp 2010; 87: 306-11.

20. Icard P, Goudet P, Charpenay C, et al. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons Study Group. World J Surg 2001; 25: 891-7.